https://www.fda.gov/media/159195/download

Vaccines and Related Biological Products Advisory Committee Meeting June 15, 2022

Lymphadenopathy was observed following vaccination in two BNT162b2 recipients 6-23 months of age and one BNT162b2 recipient 2-4 years of age; no cases were reported in the placebo groups ( Seite 6)

Wenn es nicht hilft, dann schadet es wenigstens

As of May 19, 2022, VAERS received 749,249 reports following vaccination with Pfizer-BioNTech COVID-19 Vaccine; 245 US reports were in children 6 months through 4 years of age ( Seite 11)